Earli Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Earli is a small biotechnology research company based in Redwood City, California. It designs programmable genetic constructs that activate exclusively in cancer cells and reprogram those cells to produce therapies that trigger an immune response to attack the cancer. In this approach, cancer cells are coerced to generate the proteins needed to drive their own destruction. The company sits within the biotechnology research sector with a focus on cancer therapies. In October 2021, Earli announced the appointment of Maggie Louie as Vice President of Biology. Its development draws on earlier work at Stanford University and several years of internal research aimed at programming disease cells to produce therapies.